All fields marked * are mandatory. Histology Please selectLow grade endometrioid (G1/G2)High grade endometrioid (G3)Serous carcinomaClear cell carcinomaMixed carcinomaUndifferentiated carcinomaCarcinosarcomaMesonephric-like carcinomaGastrointestinal mucinous typeNon-aggressive histological typeAggressive histological type Myometrial invasion No< 50%≥ 50% LVSI NoFocal (1-4/slide)Substantial/ extensive (≥5/slide) Uterine serosa Not involved(Sub) mesothelial involved Cx stromal invasion NoYes Ovary Not involvedUnilateral involved, limited to the ovary, without capsule invasion/rupture and negative cytologyUnilateral involved with capsule invasion/rupture/positive cytologyBilateral involved Tube Not involvedIntramucosal spread onlyUnilateral involvementBilateral involvement Vagina Not involvedInvolved Parametria Not involvedInvolved Peritoneum Not involvedPelvic peritoneum onlyAbdominal peritoneum Lymph node No metastasis Metastasis to pelvic node(s) only Metastasis to pelvic node(s) only, >0.2 mm – 2 mm and/or >200 cells Metastasis to pelvic node(s) only, >2mm Metastasis to para-aortic node(s) up to renal vessels Metastasis to para-aortic node(s) up to renal vessels, >0.2 mm – 2 mm and/or >200 cells Metastasis to para-aortic node(s) up to renal vessels, >2mm Metastasis to extra-abdominal node(s) Bladder mucosa Not involvedInvolved Intestinal mucosa Not involvedInvolved Distant metastasis NoLungLiverBoneMultiple parenchymal organs Molecular profile (optional) The fields below are used to determine molecular classification. POLE mutation Please selectNo pathogenic mutationPresence of pathogenic mutationUnknown MMR Please selectMMR deficientMMR proficientMSI low/stableMSI highUnknown p53 Please selectWild typeAbnormalUnknown Newsletter Sign Up First name Surname Email I would like to receive news from FIGO and agree to FIGO's privacy and cookies policy Please read our privacy and cookies notice. Leave this field blank